AAAAAA

   
Results: 1-19 |
Results: 19
CONJUGATION OF INTERFERON-ALPHA TO A HUMANIZED MONOCLONAL-ANTIBODY (HUBRE-3VL) ENHANCES THE SELECTIVE LOCALIZATION AND ANTITUMOR EFFECTS OFINTERFERON IN BREAST-CANCER XENOGRAFTS
Authors: OZZELLO L BLANK EW DEROSA CM CERIANI RL TOLO H KAUPPINEN HL CANTELL K
Citation: L. Ozzello et al., CONJUGATION OF INTERFERON-ALPHA TO A HUMANIZED MONOCLONAL-ANTIBODY (HUBRE-3VL) ENHANCES THE SELECTIVE LOCALIZATION AND ANTITUMOR EFFECTS OFINTERFERON IN BREAST-CANCER XENOGRAFTS, Breast cancer research and treatment, 48(2), 1998, pp. 135-147
INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL
Authors: MATTSON K NIIRANEN A RUOTSALAINEN T MAASILTA P HALME M PYRHONEN S KAJANTI M MANTYLA M TAMMINEN K JEKUNEN A SARNA S CANTELL K
Citation: K. Mattson et al., INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL, Journal of interferon & cytokine research, 17(2), 1997, pp. 103-105
IFN-GAMMA ENHANCES PRODUCTION OF IFN-ALPHA IN HUMAN MACROPHAGES BUT NOT IN MONOCYTES
Authors: CANTELL K PIRHONEN J
Citation: K. Cantell et J. Pirhonen, IFN-GAMMA ENHANCES PRODUCTION OF IFN-ALPHA IN HUMAN MACROPHAGES BUT NOT IN MONOCYTES, Journal of interferon & cytokine research, 16(6), 1996, pp. 461-463
REGRESSION OF HUMAN BREAST-CANCER XENOGRAFTS IN RESPONSE TO INTRALESIONAL TREATMENT WITH INTERFERON-ALPHA AND INTERFERON-GAMMA POTENTIATED BY TUMOR-NECROSIS-FACTOR
Authors: OZZELLO L DEROSA CM CANTELL K KAUPPINEN HL HABIF DV
Citation: L. Ozzello et al., REGRESSION OF HUMAN BREAST-CANCER XENOGRAFTS IN RESPONSE TO INTRALESIONAL TREATMENT WITH INTERFERON-ALPHA AND INTERFERON-GAMMA POTENTIATED BY TUMOR-NECROSIS-FACTOR, Journal of interferon & cytokine research, 15(10), 1995, pp. 839-848
UP-REGULATION OF A TUMOR-ASSOCIATED ANTIGEN (TAG-72) BY INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH CUTANEOUS BREAST-CANCER RECURRENCES
Authors: OZZELLO L DEROSA CM HABIF DV CANTELL K PESTKA S
Citation: L. Ozzello et al., UP-REGULATION OF A TUMOR-ASSOCIATED ANTIGEN (TAG-72) BY INTERFERON-ALPHA AND INTERFERON-GAMMA IN PATIENTS WITH CUTANEOUS BREAST-CANCER RECURRENCES, International journal of oncology, 6(5), 1995, pp. 985-991
DEVELOPMENT OF ANTIVIRAL THERAPY WITH ALPHA-INTERFERONS - PROMISES, FALSE HOPES AND ACCOMPLISHMENTS
Authors: CANTELL K
Citation: K. Cantell, DEVELOPMENT OF ANTIVIRAL THERAPY WITH ALPHA-INTERFERONS - PROMISES, FALSE HOPES AND ACCOMPLISHMENTS, Annals of medicine, 27(1), 1995, pp. 23-28
REGRESSION OF SKIN RECURRENCES OF BREAST CARCINOMAS TREATED WITH INTRALESIONAL INJECTIONS OF NATURAL INTERFERON-ALPHA AND INTERFERON-GAMMA
Authors: HABIF DV OZZELLO L DEROSA CM CANTELL K LATTES R
Citation: Dv. Habif et al., REGRESSION OF SKIN RECURRENCES OF BREAST CARCINOMAS TREATED WITH INTRALESIONAL INJECTIONS OF NATURAL INTERFERON-ALPHA AND INTERFERON-GAMMA, Cancer investigation, 13(2), 1995, pp. 165-172
INHALED RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH LUNG-CANCER - PHARMACOKINETICS AND EFFECTS ON CHEMILUMINESCENCE RESPONSES OF ALVEOLARMACROPHAGES AND PERIPHERAL-BLOOD NEUTROPHILS AND MONOCYTES
Authors: HALME M MAASILTA P REPO H RISTOLA M TASKINEN E MATTSON K CANTELL K
Citation: M. Halme et al., INHALED RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH LUNG-CANCER - PHARMACOKINETICS AND EFFECTS ON CHEMILUMINESCENCE RESPONSES OF ALVEOLARMACROPHAGES AND PERIPHERAL-BLOOD NEUTROPHILS AND MONOCYTES, International journal of radiation oncology, biology, physics, 31(1), 1995, pp. 93-101
N-GLYCOSYLATION OF HUMAN INTERFERON-GAMMA - GLYCANS AT ASN-25 ARE CRITICAL FOR PROTEASE RESISTANCE
Authors: SARENEVA T PIRHONEN J CANTELL K JULKUNEN I
Citation: T. Sareneva et al., N-GLYCOSYLATION OF HUMAN INTERFERON-GAMMA - GLYCANS AT ASN-25 ARE CRITICAL FOR PROTEASE RESISTANCE, Biochemical journal, 308, 1995, pp. 9-14
SUBCUTANEOUSLY ADMINISTERED RECOMBINANT INTERFERON-GAMMA IN HUMANS - PHARMACOKINETICS AND EFFECTS ON CHEMILUMINESCENCE RESPONSES OF ALVEOLAR MACROPHAGES, BLOOD NEUTROPHILS, AND MONOCYTES
Authors: HALME M MAASILTA P REPO H LEIRISALOREPO M TASKINEN E MATTSON K CANTELL K
Citation: M. Halme et al., SUBCUTANEOUSLY ADMINISTERED RECOMBINANT INTERFERON-GAMMA IN HUMANS - PHARMACOKINETICS AND EFFECTS ON CHEMILUMINESCENCE RESPONSES OF ALVEOLAR MACROPHAGES, BLOOD NEUTROPHILS, AND MONOCYTES, Journal of immunotherapy with emphasis on tumor immunology, 15(4), 1994, pp. 283-291
ROLE OF N-GLYCOSYLATION IN THE SYNTHESIS, DIMERIZATION AND SECRETION OF HUMAN INTERFERON-GAMMA
Authors: SARENEVA T PIRHONEN J CANTELL K KALKKINEN N JULKUNEN I
Citation: T. Sareneva et al., ROLE OF N-GLYCOSYLATION IN THE SYNTHESIS, DIMERIZATION AND SECRETION OF HUMAN INTERFERON-GAMMA, Biochemical journal, 303, 1994, pp. 831-840
ALPHA-INTERFERON AND GAMMA-INTERFERON INHIBIT PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE-EXPRESSION IN HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS
Authors: SIREN V IMMONEN I CANTELL K VAHERI A
Citation: V. Siren et al., ALPHA-INTERFERON AND GAMMA-INTERFERON INHIBIT PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE-EXPRESSION IN HUMAN RETINAL-PIGMENT EPITHELIAL-CELLS, Ophthalmic research, 26(1), 1994, pp. 1-7
THE ELIMINATION OF INDIGENOUS MEASLES, MUMPS, AND RUBELLA FROM FINLAND BY A 12-YEAR, 2-DOSE VACCINATION PROGRAM
Authors: PELTOLA H HEINONEN OP VALLE M PAUNIO M VIRTANEN M KARANKO V CANTELL K
Citation: H. Peltola et al., THE ELIMINATION OF INDIGENOUS MEASLES, MUMPS, AND RUBELLA FROM FINLAND BY A 12-YEAR, 2-DOSE VACCINATION PROGRAM, The New England journal of medicine, 331(21), 1994, pp. 1397-1402
PHARMACOKINETICS AND TOXICITY OF INHALED HUMAN NATURAL INTERFERON-BETA IN PATIENTS WITH LUNG-CANCER
Authors: HALME M MAASILTA P MATTSON K CANTELL K
Citation: M. Halme et al., PHARMACOKINETICS AND TOXICITY OF INHALED HUMAN NATURAL INTERFERON-BETA IN PATIENTS WITH LUNG-CANCER, Respiration, 61(2), 1994, pp. 105-107
VACCINATION-INDUCED HI ANTIBODY TO INFLUENZA A(H1N1) VIRUSES IN POORLY PRIMED ADULTS UNDER CIRCUMSTANCES OF LOW ANTIGENIC DRIFT
Authors: PYHALA R KINNUNEN L KUMPULAINEN V IKONEN N KLEEMOLA M CANTELL K
Citation: R. Pyhala et al., VACCINATION-INDUCED HI ANTIBODY TO INFLUENZA A(H1N1) VIRUSES IN POORLY PRIMED ADULTS UNDER CIRCUMSTANCES OF LOW ANTIGENIC DRIFT, Vaccine, 11(10), 1993, pp. 1013-1017
EFFECT OF CARBOHYDRATES ON THE PHARMACOKINETICS OF HUMAN INTERFERON-GAMMA
Authors: SARENEVA T CANTELL K PYHALA L PIRHONEN J JULKUNEN I
Citation: T. Sareneva et al., EFFECT OF CARBOHYDRATES ON THE PHARMACOKINETICS OF HUMAN INTERFERON-GAMMA, Journal of interferon research, 13(4), 1993, pp. 267-269
IS THERE A SEASONAL-VARIATION IN THE INTERFERON-PRODUCING CAPACITY OFHEALTHY-SUBJECTS
Authors: KATILA H CANTELL K APPELBERG B RIMON R
Citation: H. Katila et al., IS THERE A SEASONAL-VARIATION IN THE INTERFERON-PRODUCING CAPACITY OFHEALTHY-SUBJECTS, Journal of interferon research, 13(3), 1993, pp. 233-234
THE USE OF NATURAL INTERFERON-ALPHA CONJUGATED TO A MONOCLONAL-ANTIBODY ANTIMAMMARY EPITHELIAL MUCIN (MC5) FOR THE TREATMENT OF HUMAN BREAST-CANCER XENOGRAFTS
Authors: OZZELLO L DEROSA CM BLANK EW CANTELL K CERIANI RL HABIF DV
Citation: L. Ozzello et al., THE USE OF NATURAL INTERFERON-ALPHA CONJUGATED TO A MONOCLONAL-ANTIBODY ANTIMAMMARY EPITHELIAL MUCIN (MC5) FOR THE TREATMENT OF HUMAN BREAST-CANCER XENOGRAFTS, Breast cancer research and treatment, 25(3), 1993, pp. 265-276
CHEMOTHERAPY PLUS ALPHA-INTERFERON IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY
Authors: MATTSON K MAASILTA P HALME M NIIRANEN A PYRHONEN S RISKA H CANTELL K EKLUND J
Citation: K. Mattson et al., CHEMOTHERAPY PLUS ALPHA-INTERFERON IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY, The American review of respiratory disease, 147(4), 1993, pp. 748-748
Risultati: 1-19 |